Enviaments recents

Optical coherence tomography in multiple sclerosis: A 3-year prospective multicenter study

Calabresi, Peter A.; Green, Ari J.; Kardon, Randy; Sastre Garriga, Jaume; Barkhof, Frederik; Paul, Friedemann (Data de publicació: 2022-06-27)

Prospective multicenter study; Multiple sclerosis; Tomography

T1/T2-weighted ratio in multiple sclerosis: A longitudinal study with clinical associations

Boaventura de Oliveira, Mateus; Garcia Vidal, Aran; Vidal Jordana, Angela; Quartana, Davide; Carvajal Junco, René Yeltsin; Auger Acosta, Cristina; Alberich Jordà, Manel; Tintore Subirana, Mar; Rovira Cañellas, Alex; Montalban Gairín, Xavier; Pareto Onghena, Deborah; Sastre Garriga, Jaume (Data de publicació: 2022-07-20)

Clinically isolated syndrome; Magnetic resonance imaging; Multiple sclerosis

Structural covariance analysis for neurodegenerative and neuroinflammatory brain disorders

Gonzalez Escamilla, Gabriel; Mongay-Ochoa, Neus; Fleischer, Vinzenz; Pareto, Deborah; Rovira, Alex; Sastre Garriga, Jaume (Data de publicació: 2025-10-22)

Grey matter; Morphometric covariance networks; Neurodegeneration

Relationship between paramagnetic rim lesions and slowly expanding lesions in multiple sclerosis

Clarke, Margareta Anna; Prados, Ferran; Alberich Jordà, Manel; Pareto Onghena, Deborah; Rodríguez Barranco, Marta; Tur Gomez, Carmen; Rovira Cañellas, Alex; Sastre Garriga, Jaume; Barkhof, Frederik; Chard, Declan; Calvi, Alberto; Ciccarelli, Olga (Data de publicació: 2023-04-11)

Chronic active lesions; Multiple sclerosis; Volumetric MRI

Preliminary validity of the Draw a Shape Test for upper extremity assessment in multiple sclerosis

Graves, Jennifer; Ganzetti, Marco; Dondelinger, Frank; Lipsmeier, Florian; Belachew, Shibeshih Mitiku; Montalban Gairín, Xavier; Bernasconi, Corrado (Data de publicació: 2023-02-21)

Multiple sclerosis

Algorithm to improve the diagnosis of paraneoplastic neurological syndromes associated with SOX1 antibodies

Arnaldos-Pérez, Cristina; Vilaseca Jolonch, Andreu; Naranjo, Laura; Sabater, Lidia; Dalmau, Josep; Ruiz-García, Raquel (Data de publicació: 2023-07-04)

Cell-based assay; Paraneoplastic neurological syndromes; Small-cell lung cancer

Autoimmunity and long-term safety and efficacy of alemtuzumab for multiple sclerosis: Benefit/risk following review of trial and post-marketing data

Jones, Joanne; Vermersch, Patrick; Bass, Ann D; Boster, Aaron; Montalban Gairín, Xavier; Coles, Alasdair; Traboulsee, Anthony (Data de publicació: 2022-06-09)

Alemtuzumab; Product surveillance; Risk assessment

Humoral and cellular immune responses after 6 months of a heterologous SARS-CoV-2 booster with the protein-based PHH-1V vaccine in a phase IIb trial

Corominas Garcia, Júlia; Garriga, Carme; Prenafeta, Antoni; Moros, Alexandra; Cañete, Manuel; Barreiro, Antonio; Camacho-Arteaga, Lina; Otero-Romero, Susana; Martínez-Gómez, Xavier (Data de publicació: 2025-03-20)

Covid-19; Heterologous booster; Protein-based vaccine

Specific Patterns of Immune Cell Dynamics May Explain the Early Onset and Prolonged Efficacy of Cladribine Tablets: A MAGNIFY-MS Substudy

Hodgkinson, Suzanne; Sellebjerg, Finn; Montalban Gairín, Xavier; Chan, Andrew; Derfuss, Tobias; Wiendl, Heinz; Schmierer, Klaus (Data de publicació: 2023-02-17)

Cladribina; Cèl·lules immunitàries

Characterisation of the safety profile of evobrutinib in over 1000 patients from phase II clinical trials in multiple sclerosis, rheumatoid arthritis and systemic lupus erythematosus: an integrated safety analysis

Montalban Gairín, Xavier; Genovese, Mark C; Parsons-Rich, Dana; Le Bolay, Claire; Kao, Amy H; Guehring, Hans; Wallace, Daniel; Tomic, Davorka Lucia (Data de publicació: 2023-02-22)

Immunology; Multiple sclerosis; Rheumatology

Association of NEDA-4 With No Long-term Disability Progression in Multiple Sclerosis and Comparison With NEDA-3: A Systematic Review and Meta-analysis

Rotstein, Dalia; Solomon, Jacqueline; Sormani, Maria Pia; Montalban Gairín, Xavier; Ye, Xiang Y.; Dababneh, Dina (Data de publicació: 2022-11-18)

Esclerosis múltiple; Discapacidad; NEDA-4

Cognitive impairment in multiple sclerosis: diagnosis and monitoring

Gascón-Giménez, Francisco; Ginestal Lopez, Ricardo Constantino; Higueras Hernández, Yolanda; Téllez-Lara, Nieves; Carreres-Polo, Joan; Vidal Jordana, Angela; Meca-Lallana, Virginia (Data de publicació: 2022-06-15)

Multiple sclerosis; Neurophysiological monitoring; Neuropsychological tests

Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results

Link, Jenny; Ramanujam, Ryan; Auer, Michael; Ryner, Malin; Hassler, Signe; Bachelet, Delphine; Montalban Gairín, Xavier; Comabella Lopez, Manuel; Fissolo, Nicolás Miguel (Data de publicació: 2019-03-22)

Antibodies; Interferon beta; Multiple sclerosis

COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab

Cross, Anne H.; Delgado, Silvia; Habek, Mario; Davydovskaya, Maria; Ward, Brian J.; Montalban Gairín, Xavier; Cree, Bruce (Data de publicació: 2022-07-25)

COVID-19; Ofatumumab; Vaccination

Prognostic value of single-subject grey matter networks in early multiple sclerosis

Fleischer, Vinzenz; Gonzalez Escamilla, Gabriel; Pareto, Deborah; Sowa, Piotr; Rovira, Alex; Sastre Garriga, Jaume (Data de publicació: 2024-01-29)

Brain network measures; Graph theory; Relapsing-remitting multiple sclerosis

Retinal Optical Coherence Tomography in Neuromyelitis Optica

Specovius, Svenja; Zimmermann, Hanna G; Chien, Claudia; Cobo Calvo, Alvaro; Oertel, Frederike Cosima; Motamedi, Seyedamirhosein; Bereuter, Charlotte (Data de publicació: 2022-05-12)

Retina; Pérdida visual

Paramagnetic rims are a promising diagnostic imaging biomarker in multiple sclerosis

Meaton, Isobel; Altokhis, Amjad; Allen, Christopher Martin; Clarke, Margareta Anna; Sinnecker, Tim; Meier, Dominik; Montalban Gairín, Xavier; Rovira Cañellas, Alex (Data de publicació: 2022-12-13)

MRI; Multiple sclerosis; Biomarkers

Treatment effect modifiers of immunotherapies for relapsing-remitting multiple sclerosis—A systematic review and meta-analysis

Heesen, Christoph; Röver, Christian; Salem, Susanna; Heinz, Judith; Chard, Declan; Rio, Jordi (Data de publicació: 2024-12-27)

Multiple sclerosis; Disease-modifying therapy; Treatment response

Early Reduction of MRI Activity During 6 Months of Treatment With Cladribine Tablets for Highly Active Relapsing Multiple Sclerosis

Montalban Gairín, Xavier; Achiron, Anat; Chan, Andrew; Barkhof, Frederik; De Stefano, Nicola; Derfuss, Tobias (Data de publicació: 2022-09-12)

Active Relapsing Multiple Sclerosis; MRI; Cladribine

Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study

Montalban Gairín, Xavier; Alvarez, Enrique; Davydovskaya, Maria; Delgado, Silvia R; Bar-Or, Amit; Wiendl, Heinz (Data de publicació: 2022-07-19)

Ofatumumab; Multiple sclerosis; Pharmacokinetics

Articles científics - CEMCAT: Enviaments recents

Optical coherence tomography in multiple sclerosis: A 3-year prospective multicenter study ﻿

T1/T2-weighted ratio in multiple sclerosis: A longitudinal study with clinical associations ﻿

Structural covariance analysis for neurodegenerative and neuroinflammatory brain disorders ﻿

Relationship between paramagnetic rim lesions and slowly expanding lesions in multiple sclerosis ﻿

Preliminary validity of the Draw a Shape Test for upper extremity assessment in multiple sclerosis ﻿

Algorithm to improve the diagnosis of paraneoplastic neurological syndromes associated with SOX1 antibodies ﻿

Autoimmunity and long-term safety and efficacy of alemtuzumab for multiple sclerosis: Benefit/risk following review of trial and post-marketing data ﻿

Humoral and cellular immune responses after 6 months of a heterologous SARS-CoV-2 booster with the protein-based PHH-1V vaccine in a phase IIb trial ﻿

Specific Patterns of Immune Cell Dynamics May Explain the Early Onset and Prolonged Efficacy of Cladribine Tablets: A MAGNIFY-MS Substudy ﻿

Characterisation of the safety profile of evobrutinib in over 1000 patients from phase II clinical trials in multiple sclerosis, rheumatoid arthritis and systemic lupus erythematosus: an integrated safety analysis ﻿

Association of NEDA-4 With No Long-term Disability Progression in Multiple Sclerosis and Comparison With NEDA-3: A Systematic Review and Meta-analysis ﻿

Cognitive impairment in multiple sclerosis: diagnosis and monitoring ﻿

Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results ﻿

COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab ﻿

Prognostic value of single-subject grey matter networks in early multiple sclerosis ﻿

Retinal Optical Coherence Tomography in Neuromyelitis Optica ﻿

Paramagnetic rims are a promising diagnostic imaging biomarker in multiple sclerosis ﻿

Treatment effect modifiers of immunotherapies for relapsing-remitting multiple sclerosis—A systematic review and meta-analysis ﻿

Early Reduction of MRI Activity During 6 Months of Treatment With Cladribine Tablets for Highly Active Relapsing Multiple Sclerosis ﻿

Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study ﻿